Viking Therapeutics (VKTX) had the highest return in Q4 2022 by a mid-cap US stock, returning 240.6%.
| ASSET | QUARTER | % RETURN |
|---|---|---|
Viking Therapeutics (VKTX) | Q4 2022 | 240.58% |
Immunovant (IMVT) | Q4 2022 | 213.05% |
Biohaven (BHVN) | Q4 2022 | 117.21% |
RLX Technology (RLX) | Q4 2022 | 116.98% |
Oceaneering International (OII) | Q4 2022 | 107.72% |
F&G Annuities & Life (FG) | Q4 2022 | 100.1% |
Miniso Group Holding (MNSO) | Q4 2022 | 99.44% |
TG Therapeutics (TGTX) | Q4 2022 | 96.51% |
Tango Therapeutics (TNGX) | Q4 2022 | 95.95% |
Vaxcyte (PCVX) | Q4 2022 | 95.71% |
Kingsoft Cloud Holdings (KC) | Q4 2022 | 88.67% |
Enliven Therapeutics (ELVN) | Q4 2022 | 77.06% |
Transocean (RIG) | Q4 2022 | 75.38% |
Manchester United (MANU) | Q4 2022 | 75.28% |
Melco Resorts & Entertainment (MLCO) | Q4 2022 | 72.93% |
Turkcell Iletisim Hizmetleri AS (TKC) | Q4 2022 | 68.66% |
Powell Industries (POWL) | Q4 2022 | 65.54% |
HUTCHMED DRC (HCM) | Q4 2022 | 65.14% |
Tidewater (TDW) | Q4 2022 | 63.78% |
Pitney Bowes (PBI) | Q4 2022 | 63.5% |
Vipshop (VIPS) | Q4 2022 | 62.38% |
Pharvaris (PHVS) | Q4 2022 | 62.34% |
Vista Energy, SAB de CV (VIST) | Q4 2022 | 60.12% |
Magnite (MGNI) | Q4 2022 | 59.49% |
Enel Chile SA ADR (ENIC) | Q4 2022 | 58.45% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.